WHAT: The 35th annual CTRC-AACR San Antonio Breast Cancer Symposium, where close to 7,500 researchers, clinicians and advocates from around the world are gathering to present and hear about the latest research, trends and topics of discussion in breast cancer, including drug trials and treatment methods.
WHEN: Dec. 4-8, 2012
WHERE: Henry B. Gonzalez Convention Center
The first sessions begin this afternoon. A link to today’s program and the rest of the symposium can be found here.
The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio, the AACR and Baylor College of Medicine jointly present the symposium.
MEDIA REGISTRATION AND PRESS ROOM:
As in previous years, the press room will be located in Room 217A/B/C of the Henry B. Gonzales Convention Center. We will open tomorrow morning at 8 a.m. CT and remain open until 7 p.m. CT that evening.
Press conferences will be held Wednesday, Thursday and Friday this week at 7:30 a.m.
You can pick up your badge, program and other materials in the main registration area at the designated “PRESS REGISTRATION” window. This area opens at 8 a.m. CT. Electronic press kits can be picked up in the press room.
The press room will not serve lunch, but there will be a concession stand nearby and beverage service throughout the day.
The room is set up for wireless Internet access. Just select SABCS 2012.
There are several landline phones scattered throughout the room for your use.
There are four public computers in the back of the room by the television screens, and these are networked to the printer. Please limit your use of these computers to 10 minutes.
The CTRC-AACR San Antonio Breast Cancer Symposium press room will broadcast the general session on the big-screen TVs in the back of the room.
Paper copies of the slides are available on request.
The Cancer Therapy & Research Center (CTRC) at The University of Texas Health Science Center at San Antonio is one of the elite academic cancer centers in the country to be named a National Cancer Institute (NCI) Designated Cancer Center, and is one of only four in Texas. A leader in developing new drugs to treat cancer, the CTRC Institute for Drug Development (IDD) conducts one of the largest oncology Phase I clinical drug programs in the world, and participates in development of cancer drugs approved by the U.S. Food & Drug Administration. For more information, visit www.ctrc.net.